DaVita Inc., US23918K1088

DaVita Inc. stock slips 0.65 percent as earnings support outlook

Published on 09/22/2026 at 16:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DaVita Inc. stock closed at USD 182.67 on September 21, 2026, 26.2 percent below its yearly high. MarketBeat sees a USD 233.43 consensus target.

Modernes Dialysezentrum mit Pflegepersonal und Patienten in heller Klinikumgebung
DaVita Inc. Dialysezentrum mit modernen Behandlungsstühlen und medizinischem Pflegepersonal in Denver, ISIN US23918K1088, Illustration mit AI erstellt.

DaVita Inc. stock (ISIN US23918K1088) closed at USD 182.67 on the New York Stock Exchange on September 21, 2026, down USD 1.19 or 0.65 percent from the prior close. The quotation stood 26.2 percent below the 52-week high of USD 247.49 and 80.9 percent above the 52-week low of USD 101.00.

Stock remains below yearly high

The September 21, 2026 session ranged from USD 182.03 to USD 185.00, with 554,745 shares traded. That volume was below the reported average of 927,037 shares, while market capitalization stood at USD 11.65 billion on the same dated snapshot.

The market picture is therefore defined by a modest daily decline and a wide distance from the yearly peak, rather than by a new trading extreme. For investors, the comparison with the 52-week range matters because the stock remains materially above its low while still below its high.

Earnings support the outlook

Recent coverage linked the company outlook to earnings growth, while the latest available market assessment placed the average analyst price target at USD 233.43 on September 18, 2026. At the then closing price of USD 183.59, that target was USD 49.84 higher, or approximately 27.1 percent above the reference level.

According to Ad Hoc News on September 21, 2026, MarketBeat described DaVita Inc. as carrying a Moderate Buy consensus rating with an average rating score of 2.57. The report tied that assessment to the company's second-quarter results and upbeat outlook, making earnings progress and cash generation the key factors behind the positive consensus.

The counter-factor is valuation distance: the consensus target remains below the 52-week high of USD 247.49, while the September 21 closing price was USD 0.92 below the September 18 close of USD 183.59. The figures show that a constructive analyst view has not translated into a return to the yearly peak.

DaVita Inc. stock closes at USD 182.67

DaVita Inc. stock closed at USD 182.67 on the New York Stock Exchange on September 21, 2026, with a daily change of minus 0.65 percent. The market capitalization was USD 11.65 billion, and the 52-week range was USD 101.00 to USD 247.49.

DaVita Inc. stock facts

  • Company: DaVita Inc.
  • ISIN: US23918K1088
  • Ticker: DVA
  • Trading venue: New York Stock Exchange
  • Price as of September 21, 2026: USD 182.67
  • Market capitalization: USD 11.65 billion as of September 21, 2026
  • Sector / Industry: Health Care / Health Care Services
  • Index membership: S&P 500

More news and analyses on DaVita Inc. stock

Disclaimer...

en | US23918K1088 | DAVITA INC. | boerse | 70156646 | bgmi